Workflow
Road Technologies
icon
Search documents
Ingevity Q2 Earnings Surpass Estimates, Revenues Decline Y/Y
ZACKSยท 2025-08-11 16:01
Core Insights - Ingevity Corporation (NGVT) reported a second-quarter 2025 loss of $146.5 million or $4.02 per share, an improvement from a loss of $283.7 million or $7.81 per share in the same quarter last year [1] - Adjusted earnings for the quarter were $1.39 per share, up from $1.01 a year ago, surpassing the Zacks Consensus Estimate of $1.02 per share [1][9] - Revenues decreased by 6.5% year over year to $365.1 million, primarily due to lower sales in the Performance Chemicals segment [2] Segment Performance - The Performance Chemicals division generated revenues of $167.9 million, down approximately 9.5% year over year, with Road Technologies sales at $119.5 million (down 7.4%) and Industrial Specialties at $48.4 million (down 14.2%) [3] - EBITDA for the Performance Chemicals segment increased by 244% to $32 million, attributed to successful repositioning and cost savings [3] - Performance Materials revenues fell by 2.1% year over year to $153.9 million, impacted by lower sales in Asia and Europe, while North America saw higher sales; segment EBITDA was $77.1 million, down 6.2% [4] - Advanced Polymer Technologies segment sales decreased by 9.6% to $43.3 million due to reduced customer demand, particularly in Europe, with segment EBITDA down 90.8% to $0.9 million [5] Financial Overview - Operating cash flow for the second quarter was $79 million, with free cash flow of $66.8 million; no share repurchases occurred during the quarter, leaving $353.4 million remaining under the current $500 million authorization [6] - Net leverage improved to 3x from 3.3x in the previous quarter [6] 2025 Outlook - NGVT has revised its 2025 EBITDA guidance upwards, now expecting adjusted EBITDA between $390 million and $415 million, compared to the previous range of $380 million to $415 million; sales estimates remain between $1.25 billion and $1.40 billion [7][9] Stock Performance - NGVT shares have increased by 50.8% over the past year, outperforming the industry average increase of 1.2% [8]
Ingevity(NGVT) - 2025 Q1 - Earnings Call Presentation
2025-05-06 11:19
Financial Performance - Net sales decreased by 16.5% from $340.1 million in Q1 2024 to $284 million in Q1 2025[7] - Adjusted EBITDA increased by 22.7% from $74.4 million in Q1 2024 to $91.3 million in Q1 2025[7] - Adjusted EBITDA margin increased by 1020 bps from 21.9% in Q1 2024 to 32.1% in Q1 2025[7] - Diluted adjusted EPS increased by 110.6% from $0.47 in Q1 2024 to $0.99 in Q1 2025[7] - Free cash flow improved from negative $28.7 million in Q1 2024 to positive $15.4 million in Q1 2025[71] Segment Performance - Performance Materials net sales increased by 1.2% from $145.1 million to $146.8 million, with a 1.4% increase in Segment EBITDA from $78 million to $79.1 million[18] - Advanced Polymer Technologies net sales decreased by 12.1% from $48 million to $42.2 million, but Segment EBITDA increased by 31.6% from $9.5 million to $12.5 million[23] - Performance Chemicals net sales decreased by 35.4% from $147 million to $95 million, but Segment EBITDA improved by $10.3 million from negative $10.6 million to negative $0.3 million[28] Guidance and Outlook - The company widened its revenue guidance to $1.25 - $1.4 billion and affirmed free cash flow guidance of $220 - $260 million[33] - The company expects net debt ratio to be below 2.8x by year end[17, 33] - A 10% reduction in North America auto production is expected to lower Performance Materials EBITDA by approximately $15-$20 million[33, 34]